Studies in prostate cancer, thyroid cancer, and glioma have shown that FOXA1 is highly expressed in tumor tissues, has a significant correlation with tumor grade, invasion, and metastasis and poor prognosis of patients, and plays a role in promoting tumorigenesis and development [10–12]. Here, FOXA1 is linked to central nervous system cancer.